Nurse Practitioner, Family · Pensacola, FL
NPI
1558738930
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
6
Medicare group memberships
Hospitals
1
Hospital affiliations
1295 W Fairfield Dr
Pensacola, FL, 32501
Phone (850) 595-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
5,300 services
Medicare patients, 2024
254
Average age 73
Drug cost, 2024
$1.8M
728 prescriptions
Company payments, 2025
$2,198
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maryann E Westbrook was code 95004 (test - miscellaneous), 1,857 times for 30 patients. In total Maryann E Westbrook billed 5,300 services in 26 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,857 | 30 | $2.28 | $4,238 |
| 95115 Treatment - Miscellaneous | Office | 267 | 27 | $6.04 | $1,613 |
| 99214 Office E&M - Established | Office | 265 | 194 | $78.14 | $21K |
| 94060 Pulmonary Function Testing | Office | 127 | 100 | $23.89 | $3,034 |
| 95117 Treatment - Miscellaneous | Office | 117 | 16 | $6.69 | $782 |
| 96160 E&M - Miscellaneous | Office | 72 | 57 | $1.67 | $120 |
| 99213 Office E&M - Established | Office | 68 | 61 | $50.92 | $3,463 |
| 94010 Pulmonary Function Testing | Office | 54 | 51 | $16.89 | $912 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 42 | 42 | $10.89 | $457 |
| 94729 Pulmonary Function Testing | Office | 34 | 32 | $32.73 | $1,113 |
| 94726 Pulmonary Function Testing | Office | 34 | 32 | $32.54 | $1,106 |
| 96401 Chemotherapy Administration | Office | 14 | 11 | $45.42 | $636 |
By year: 2022 $11K for 1,180 services; 2023 $32K for 1,519 services; 2024 $96K for 5,300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maryann E Westbrook prescribed most often to Medicare patients was Montelukast Sodium, with 71 prescriptions and refills. In total Maryann E Westbrook wrote 728 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 71 | 177 | 23 | $853 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 68 | 98 | 18 | $62K |
| Fluticasone Propionate Generic | 64 | 117 | 31 | $919 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 52 | 65 | 30 | $1,991 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 43 | 44 | 19 | $2,244 |
| Epinephrine Generic | 37 | 37 | 23 | $5,492 |
| Ipratropium Bromide Generic | 34 | 36 | Under 11 | $804 |
| Azelastine Hcl Generic | 33 | 58 | 12 | $1,086 |
| Spiriva Respimat Tiotropium Bromide | 33 | 45 | 15 | $23K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 31 | 37 | 11 | $22K |
| Levocetirizine Dihydrochloride Generic | 27 | 69 | 12 | $459 |
| Dupixent Pen Dupilumab | 20 | 20 | Under 11 | $94K |
| Triamcinolone Acetonide Generic | 20 | 24 | Under 11 | $171 |
| Symbicort Budesonide/Formoterol Fumarate | 16 | 36 | Under 11 | $5,685 |
| Breo Ellipta Fluticasone/Vilanterol | 15 | 21 | Under 11 | $5,527 |
Brand drugs: 370 claims; generic drugs: 358 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maryann E Westbrook $2,198 ($2,198 in general payments such as food, travel and fees) from 20 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $482.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $482 |
| Genzyme Corporation SNY | 15 | $366 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $263 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $130 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $98.99 |
| GlaxoSmithKline, LLC. GSK | 5 | $89.36 |
| Genentech USA, Inc. ROG.SW | 4 | $75.63 |
| Grifols USA, LLC | 3 | $75.16 |
| Optinose US, Inc. | 3 | $69.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.